XBI

SPDR S&P Biotech ETF

Down$91.95
$-1.31
(-1.4%)
As of 12:01:42 PM EDT | 1/24/20  |  Market Open

XBI Trading Data

Open

$93.73

Low Price

$91.58

High Price

$93.77

Previous Last Price

$93.26

Bid Size

$91.95 X 400

Ask Size

$91.97 X 700

XBI Portfolio Data

AUM

$4,426,568,800

Shares

47,475

PE Ratio

17.99

Price / Book Ratio

5.3

Expense Ratio

0.35

Net Asset Value

$93.24

Volume

Volume

1,830,557

Avg. Volume (YDT)

5,551,044

Dollar Volume

$1,403,468,437

Weekly Avg. Volume

4,583,361

Monthly Avg. Volume

5,154,560

Quarterly Avg. Volume

4,803,847

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Exelixis Inc. (EXEL)
1.93%
BioMarin Pharmaceutical Inc. (BMRN)
1.9%
Exact Sciences Corporation (EXAS)
1.9%
Invitae Corp. (NVTA)
1.89%
Vertex Pharmaceuticals Incorporated (VRTX)
1.87%
Global Blood Therapeutics Inc (GBT)
1.83%
bluebird bio Inc. (BLUE)
1.82%
United Therapeutics Corporation (UTHR)
1.8%
Alexion Pharmaceuticals Inc. (ALXN)
1.76%
Amgen Inc. (AMGN)
1.74%

Total XBI Holdings

Total Holdings: 126

Exelixis Inc. (EXEL)
1.93%
BioMarin Pharmaceutical Inc. (BMRN)
1.9%
Exact Sciences Corporation (EXAS)
1.9%
Invitae Corp. (NVTA)
1.89%
Vertex Pharmaceuticals Incorporated (VRTX)
1.87%
Global Blood Therapeutics Inc (GBT)
1.83%
bluebird bio Inc. (BLUE)
1.82%
United Therapeutics Corporation (UTHR)
1.8%
Alexion Pharmaceuticals Inc. (ALXN)
1.76%
Amgen Inc. (AMGN)
1.74%
AbbVie Inc. (ABBV)
1.73%
SAGE Therapeutics Inc. (SAGE)
1.72%
Alnylam Pharmaceuticals Inc (ALNY)
1.71%
Seattle Genetics Inc. (SGEN)
1.71%
Ionis Pharmaceuticals Inc. (IONS)
1.69%
Biogen Inc. (BIIB)
1.69%
Gilead Sciences Inc. (GILD)
1.68%
Regeneron Pharmaceuticals Inc. (REGN)
1.66%
ACADIA Pharmaceuticals Inc. (ACAD)
1.66%
Neurocrine Biosciences Inc. (NBIX)
1.63%
Moderna Inc. (MRNA)
1.59%
Sarepta Therapeutics Inc. (SRPT)
1.56%
Ligand Pharmaceuticals Incorporated (LGND)
1.5%
Incyte Corporation (INCY)
1.5%
Ultragenyx Pharmaceutical Inc. (RARE)
1.48%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
1.48%
Intercept Pharmaceuticals Inc. (ICPT)
1.45%
PTC Therapeutics Inc. (PTCT)
1.42%
Agios Pharmaceuticals Inc. (AGIO)
1.42%
Immunomedics Inc. (IMMU)
1.42%
Mirati Therapeutics Inc. (MRTX)
1.41%
Blueprint Medicines Corp. (BPMC)
1.41%
Apellis Pharmaceuticals Inc. (APLS)
1.33%
Amicus Therapeutics Inc. (FOLD)
1.31%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.25%
Alkermes Plc (ALKS)
1.19%
Myriad Genetics Inc. (MYGN)
1.09%
Natera Inc. (NTRA)
1.08%
Iovance Biotherapeutics Inc (IOVA)
1.06%
FibroGen Inc. (FGEN)
1.05%
REGENXBIO Inc. (RGNX)
1.04%
Emergent BioSolutions Inc. (EBS)
1.03%
Ra Pharmaceuticals Inc. (RARX)
1.02%
Aimmune Therapeutics Inc (AIMT)
1.01%
Coherus BioSciences Inc. (CHRS)
1%
Deciphera Pharmaceuticals Inc. (DCPH)
0.99%
Heron Therapeutics Inc (HRTX)
0.97%
CareDx Inc. (CDNA)
0.89%
Arena Pharmaceuticals Inc. (ARNA)
0.87%
Karyopharm Therapeutics Inc. (KPTI)
0.81%
Insmed Incorporated (INSM)
0.77%
Allakos Inc. (ALLK)
0.77%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.77%
Esperion Therapeutics Inc. (ESPR)
0.76%
Turning Point Therapeutics Inc. (TPTX)
0.72%
Halozyme Therapeutics Inc. (HALO)
0.71%
Veracyte Inc (VCYT)
0.69%
Editas Medicine Inc. (EDIT)
0.66%
Fate Therapeutics Inc. (FATE)
0.65%
Acceleron Pharma Inc (XLRN)
0.65%
Puma Biotechnology Inc. (PBYI)
0.62%
Radius Health Inc (RDUS)
0.61%
Clovis Oncology Inc. (CLVS)
0.58%
Madrigal Pharmaceuticals Inc. (MDGL)
0.58%
Adverum Biotechnologies Inc (ADVM)
0.56%
Momenta Pharmaceuticals Inc. (MNTA)
0.55%
Allogene Therapeutics Inc. (ALLO)
0.55%
Portola Pharmaceuticals Inc. (PTLA)
0.55%
TG Therapeutics Inc. (TGTX)
0.55%
Epizyme Inc. (EPZM)
0.53%
Catalyst Pharmaceuticals Inc. (CPRX)
0.53%
AnaptysBio Inc. (ANAB)
0.51%
Xencor Inc. (XNCR)
0.48%
Sangamo Therapeutics Inc. (SGMO)
0.47%
Enanta Pharmaceuticals Inc. (ENTA)
0.47%
Flexion Therapeutics Inc. (FLXN)
0.42%
Eagle Pharmaceuticals Inc. (EGRX)
0.42%
Athenex Inc. (ATNX)
0.41%
Atara Biotherapeutics Inc (ATRA)
0.41%
G1 Therapeutics Inc. (GTHX)
0.41%
OPKO Health Inc. (OPK)
0.4%
AMAG Pharmaceuticals Inc. (AMAG)
0.39%
Anika Therapeutics Inc. (ANIK)
0.38%
Viking Therapeutics Inc. (VKTX)
0.38%
Principia Biopharma Inc. (PRNB)
0.36%
Vanda Pharmaceuticals Inc. (VNDA)
0.35%
Retrophin Inc. (RTRX)
0.33%
Vericel Corporation (VCEL)
0.33%
Achillion Pharmaceuticals Inc. (ACHN)
0.33%
Krystal Biotech Inc. (KRYS)
0.32%
Intrexon Corporation (XON)
0.3%
Denali Therapeutics Inc. (DNLI)
0.3%
Intellia Therapeutics Inc. (NTLA)
0.3%
BridgeBio Pharma Inc. (BBIO)
0.29%
Kodiak Sciences Inc. (KOD)
0.28%
ZIOPHARM Oncology Inc. (ZIOP)
0.27%
Alector Inc. (ALEC)
0.27%
Cytokinetics Incorporated (CYTK)
0.27%
Y-mAbs Therapeutics Inc. (YMAB)
0.26%
MacroGenics Inc. (MGNX)
0.26%
Dicerna Pharmaceuticals Inc. (DRNA)
0.26%
ImmunoGen Inc. (IMGN)
0.26%
Gossamer Bio Inc. (GOSS)
0.26%
Voyager Therapeutics Inc. (VYGR)
0.25%
Twist Bioscience Corp. (TWST)
0.24%
Dynavax Technologies Corporation (DVAX)
0.23%
Chemocentryx Inc. (CCXI)
0.22%
NextCure Inc. (NXTC)
0.21%
Akebia Therapeutics Inc. (AKBA)
0.21%
Stemline Therapeutics Inc. (STML)
0.21%
Progenics Pharmaceuticals Inc. (PGNX)
0.21%
BioCryst Pharmaceuticals Inc. (BCRX)
0.2%
Akcea Therapeutics Inc. (AKCA)
0.18%
Rhythm Pharmaceuticals Inc. (RYTM)
0.17%
Rocket Pharmaceuticals Inc. (RCKT)
0.15%
STATE STREET INSTITUTIONAL LIQ STATE STR (70286227)
0.15%
Agenus Inc. (AGEN)
0.14%
AVROBIO Inc (AVRO)
0.13%
Homology Medicines Inc. (FIXX)
0.13%
Kura Oncology Inc. (KURA)
0.12%
Karuna Therapeutics Inc. (KRTX)
0.12%
Spectrum Pharmaceuticals Inc. (SPPI)
0.11%
Kadmon Holdings Inc. (KDMN)
0.09%
Prothena Corp. Plc (PRTA)
0.08%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-0.89

Beta

1.68

Leverage

Long

Standard Deviation

5.41

XBI Dividends

Dividend Date

2019-12-20

Latest Dividend

0.001

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

0.02

XBI Performance

YTD Return

-3.45%

1 Year Return

14%

3 Year Return

47.05%

5 Year Return

40.14%

10 Year Return

406.11%

XBI Related Articles

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.